asiatic acid has been researched along with Cirrhosis, Liver in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, JC; Tu, LL; Yin, LN; Zhang, Y; Zhang, YW; Zheng, GL | 1 |
| Guan, S; He, XL; Huang, XZ; Li, J; Li, S; Li, Y; Zhang, L; Zhou, LP | 1 |
| Chen, X; Chen, Y; Wang, S; Yin, L; Zhang, Y; Zhao, P; Zhou, Y | 1 |
| Chen, Q; Fan, J; Guo, A; Wang, R; Wei, L; Zhang, H | 1 |
| Chen, Q; Fan, J; Wang, R; Wei, L; Zhang, H; Zhou, X | 1 |
| Bao, X; Dong, L; Jiang, L; Li, Y; Yang, F; Yin, S; Yuan, L; Yuan, M; Zhang, X | 1 |
| He, RH; Huang, XR; Lan, HY; Meng, XM; Tan, JJ; Tang, LX; Yang, G; Zhou, L | 1 |
7 other study(ies) available for asiatic acid and Cirrhosis, Liver
| Article | Year |
|---|---|
Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis.
Topics: Animals; Carbon Tetrachloride; Cell Line; Cell Proliferation; Chemistry, Pharmaceutical; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Liberation; Lipids; Liver; Liver Cirrhosis; Liver Function Tests; Male; Mice; Mice, Inbred ICR; Nanostructures; Particle Size; Pentacyclic Triterpenes; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Surface Properties; Ursodeoxycholic Acid | 2021 |
Asiatic acid alleviates liver fibrosis via multiple signaling pathways based on integrated network pharmacology and lipidomics.
Topics: Animals; Arachidonic Acid; Hepatic Stellate Cells; Humans; Lipidomics; Liver; Liver Cirrhosis; Mice; Network Pharmacology; Pentacyclic Triterpenes; Signal Transduction | 2022 |
Preparation and evaluation of PEGylated asiatic acid nanostructured lipid carriers on anti-fibrosis effects.
Topics: Administration, Oral; Animals; Biological Availability; Centella; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Intestinal Absorption; Lipids; Liver Cirrhosis; Male; Mice; Mice, Inbred ICR; Nanostructures; Particle Size; Pentacyclic Triterpenes; Polyethylene Glycols; Rats; Rats, Sprague-Dawley | 2020 |
Asiatic acid attenuates CCl
Topics: Actins; Animals; Anti-Inflammatory Agents; Apoptosis; Carbon Tetrachloride; Caspase 3; Hepatocytes; Liver; Liver Cirrhosis; Male; Pentacyclic Triterpenes; Phosphatidylinositol 3-Kinases; Protective Agents; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; TOR Serine-Threonine Kinases | 2018 |
Asiatic acid ameliorates CCl
Topics: Animals; Antioxidant Response Elements; Carbon Tetrachloride; I-kappa B Proteins; Janus Kinase 1; Liver Cirrhosis; Male; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Pentacyclic Triterpenes; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor | 2018 |
Synthesis and evaluation of asiatic acid derivatives as anti-fibrotic agents: structure/activity studies.
Topics: Animals; Chemistry Techniques, Synthetic; Female; Liver Cirrhosis; Pentacyclic Triterpenes; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2015 |
Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro.
Topics: Animals; Blotting, Western; Carbon Tetrachloride; Cell Line; Collagen Type I; Gene Knockdown Techniques; Hepatic Stellate Cells; Immunohistochemistry; Liver; Liver Cirrhosis; Liver Function Tests; Male; Pentacyclic Triterpenes; Phosphorylation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Signal Transduction; Smad Proteins; Time Factors; Transforming Growth Factor beta; Up-Regulation | 2012 |